← Back to Patent Explorer
US4017603A Expired / Lapsed US ⏱️ 0.0 years remaining

Water-soluble pharmaceutical complexes of partricin or an alkyl ester thereof with sodium desoxycholate or sodium dehydrocholate

Assignee: Prodotti Antibiotici SpA
•
Filing: 1975-08-29
•
Granted: 1977-04-12
•
Expires: 1995-08-29
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention provides a water-soluble pharmaceutical complex, comprising the antibiotic partricin and/or an alkyl ester thereof and sodium desoxycholate and/or sodium dehydrocholate.

Inventors

  • 👤 Rodolfo Ferrari
  • 👤 Ernani Dell'Acqua

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 06:43
CPC Classifications
C; C07; C07H; C07H17/00; C07H17/04; C07H17/08; C07J; C07J9/00; C07J9/005

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 148 words
A water-soluble pharmaceutical complex, comprising an antibiotic selected from the group consisting of partricin, partricin methyl ester and partricin ethyl ester and a complex-forming compound selected from the group consisting of sodium desoxycholate and sodium dehydrocholate, wherein the weight ratio of the antibiotic to the complex-forming compound is about 1:1, said partricin having an Rf value of about 0.50 on silica gel using butanol-ethanol-acetone-25% ammonium hydroxide in a ratio of 2:5:1:3 as eluent, ultraviolet absorption maxima at 410, 379, 359 and 341 mμ in ethanol at a concentration of about 0.01 mg/ml, infrared absorption maxima at 3355, 1704, 1596, 1175, 1070, 995 and 850 cm - 1 in nujol, and an elemental analysis of C = 62.8%, H = 7.9%, N= 3.2% and O =25.2% said complex having an ultraviolet absorption spectrum and Rf value equal to the ultraviolet absorption spectrum and Rf value of the antibiotic alone.
Claim 2
Dependent Claim 148 words
A water-soluble pharmaceutical complex, comprising an antibiotic selected from the group consisting of partricin, partricin methyl ester and partricin ethyl ester and a complex-forming compound selected from the group consisting of sodium desoxycholate and sodium dehydrocholate, wherein the weight ratio of the antibiotic to the complex-forming compound is about 1:1, said partricin having an Rf value of about 0.50 on silica gel using butanol-ethanol-acetone-25% ammonium hydroxide in a ratio of 2:5:1:3 as eluent, ultraviolet absorption maxima at 410, 379, 359 and 341 mμ in ethanol at a concentration of about 0.01 mg/ml, infrared absorption maxima at 3355, 1704, 1596, 1175, 1070, 995 and 850 cm - 1 in nujol, and an elemental analysis of C = 62.8%, H = 7.9%, N= 3.2% and O =25.2% said complex having an ultraviolet absorption spectrum and Rf value equal to the ultraviolet absorption spectrum and Rf value of the antibiotic alone.
Claim 3
Dependent Claim 14 words
A complex according to claim 1, wherein the antibiotic is the partricin methyl ester.
Claim 4
Dependent Claim 14 words
A complex according to claim 1, wherein the antibiotic is the partricin ethyl ester.
Claim 5
Dependent Claim 28 words
A pharmaceutical composition, comprising a complex according to claim 1, in admixture with a member selected from the group consisting of solid and liquid pharmaceutical diluents and carriers.

References Cited (Backward Citations)

US3773925A Cited
US3780173A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-04-11 1980-10-11 1981-04-12 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-04-11 1984-10-11 1985-04-12 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-04-11 1988-10-11 1989-04-12 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag